Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
When a GHRH analogue and a GHRP are administered together, they act on two independent receptor systems simultaneously, producing a synergistic effect on GH release that exceeds what either compound achieves alone
They can also help maintain healthy weight and prevent long-term complications
Administration and Safety TB-500 Administration: Commonly given via subcutaneous injection Typically used in 46 week cycles Initial phase: 23 injections per week Maintenance phase: Reduced frequency as directed by a healthcare provider BPC-157 Administration: Can be taken via subcutaneous injection, localized injection, or oral capsule (for gut health) Dosage varies depending on injury type and severity Can be used for short-term injury recovery or longer cycles for chronic conditions Safety Note: Both TB-500 and BPC-157 should be used under medical supervision
Weeks 6 to 12: optimization The extended phase is about fine-tuning
